Global and regional cancer burden attributable to modifiable risk factors to inform prevention
Summary
Cancer remains a leading cause of morbidity globally, largely attributable to modifiable risks. We estimated the 2022 global and national cancer burden attributable to 30 such factors, including tobacco smoking, alcohol consumption, high body mass index, insufficient physical activity, smokeless tobacco and areca nut, suboptimal breastfeeding, air pollution, ultraviolet radiation, 9 infectious agents and 13 occupational exposures, to inform prevention efforts. Using GLOBOCAN data for 36 ca
Content
# Global and regional cancer burden attributable to modifiable risk factors to inform prevention
*Published: 2026 Apr*
Cancer remains a leading cause of morbidity globally, largely attributable to
modifiable risks. We estimated the 2022 global and national cancer burden
attributable to 30 such factors, including tobacco smoking, alcohol consumption,
high body mass index, insufficient physical activity, smokeless tobacco and
areca nut, suboptimal breastfeeding, air pollution, ultraviolet radiation, 9
infectious agents and 13 occupational exposures, to inform prevention efforts.
Using GLOBOCAN data for 36 cancer sites in 185 countries, we applied prevalence
data from around 2012 to reflect exposure-cancer latency and estimated
Levin-based or Miettinen-based population-attributable fractions (PAFs) or
direct estimates where applicable. Combined PAFs accounting for overlapping
exposures were derived by cancer, sex, country and region. In 2022, an estimated
7.1 million of 18.7 million new cancer cases (37.8%) were attributable to 30
modifiable risk factors-2.7 million (29.7%) in women and 4.3 million (45.4%) in
men. The proportion of preventable cancers ranged from 24.6% to 38.2% in women
and from 28.1% to 57.2% in men across regions. Smoking (15.1%), infections
(10.2%) and alcohol consumption (3.2%) were the leading contributors to cancer
burden. Lung, stomach and cervical cancers represented nearly half of
preventable cancers. Strengthening efforts to reduce modifiable exposures
remains central to global cancer prevention.
DOI: 10.1038/s41591-026-04219-7